Letters
β blockers for heart failure
Research into “real world” older patients is needed
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3136 (Published 07 June 2016) Cite this as: BMJ 2016;353:i3136- Conal J Cunningham, consultant geriatrician
- Falls and Blackout Unit, St James's Hospital, Dublin 8, Republic of Ireland
- ccunningham{at}stjames.ie
Kotecha and colleagues’ meta-analysis establishes that β blockers are beneficial in patients aged 40-85 with heart failure and reduced ejection fraction who are able to tolerate them. In the original trials most patients seemed to tolerate these drugs.1
But it does not tell us how well older people in clinical practice can tolerate β blockers, and the authors seem to extrapolate beyond their data. All the randomised …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.